Immunis.AI
Immunis.AI provides a non-invasive way to profile a patient’s immune response and detect disease signals from a blood sample. The company performs immunogenomic analysis—using high-throughput sequencing and bioinformatics—to characterize circulating immune cells and disease-associated genomic signatures. Its platform is a clinical biotech diagnostics solution focused initially on oncology, enabling researchers and clinicians to monitor disease and treatment response. The offering targets healthcare and life-science organizations rather than individual consumers. Immunis.AI plans to expand its blood-based immunogenomic assays to additional diseases and therapeutic applications.
Immunis.AI
Immunis.AI provides a non-invasive way to profile a patient’s immune response and detect disease signals from a blood sample. The company performs immunogenomic analysis—using high-throughput sequencing and bioinformatics—to characterize circulating immune cells and disease-associated genomic signatures. Its platform is a clinical biotech diagnostics solution focused initially on oncology, enabling researchers and clinicians to monitor disease and treatment response. The offering targets healthcare and life-science organizations rather than individual consumers. Immunis.AI plans to expand its blood-based immunogenomic assays to additional diseases and therapeutic applications.